Parathyroid hormone analogues for treatment of osteoporosis and hypercalcaemia

Bibliography

• DEMPSTER DW, COSMAN F, PARISIEN M, SHEN V, LIND-SAY R: Anabolic actions of parathyroid hormone on bone. In: Hormonal Regulation of Bone Mineral Metabo-lism. Bikle DD, Negrovilar A (Eds.), Endocrine Reviews Monographs, 4 (1995) 227–246.
   Google Scholar
• MORLEY P, WHITFIELD JF, WILLICK GE: Anabolic effects of parathyroid hormone on bone. Trends EndocrinoL MetaboL (1997) 8:225–231.
   PubMed Web of Science ®Google Scholar
• SEGRE GV, GOLDRING SR: Receptors for secretin, calci-tonin, parathyroid hormone (PTH)/PTH-related pep-tide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family. Trends EndocrinoL MetaboL (1993) 4:309–314.
   PubMed Web of Science ®Google Scholar
• USDIN TB, GRUBER C, BONNER TI: Identification andfunctional expression of a receptor selectively recog-nizing parathyroid hormone, the PTH2 receptor. J. Biol. Chem. (1995) 270:15455–8.
   PubMed Web of Science ®Google Scholar
• WHITFIELD JF, MORLEY P, LANGILLE R, WILLICK GE:Adenylyl cyclase-activating anabolic agents: parathy-roid hormone and prostaglandin E. In: Anabolic Treat-ments for Osteoporosis. Whitfield JF, Morley P (Eds.), Boca Raton, FL, CRC Press (1997) 108–149.
   Google Scholar
• BROADUS AE, STEWART AF: Parathyroid hormone-related protein - structure, processing, and physiologi-cal actions. In: Parathyroids: Basic and Clinical Concepts. Bilezikian JP (Ed.), Raven Press, New York (1994) 259–294.
   Google Scholar
• ORWOLL ES, KLEIN RF: Osteoporosis in men. Endocr. Rev. (1995) 16:87–116.
   PubMed Web of Science ®Google Scholar
• SEEMAN E, TSALAMANDRIS C, BASS S. PEARCE G: Presentand future of osteoporosis therapy. Bone (1995) 17:23S–29S.
   Google Scholar
• LUFKIN EG, ORY SJ: Postmenopausal oestrogen ther-apy. Trends EndocrinoL MetaboL (1995) 6:50–54.
   Google Scholar
• IKEGAME M, RAKOPOULOS M, MARTIN TJ et al.: Effects ofcontinuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. J. Bone Miner. Res. (1996) 11:456–465.
   PubMedGoogle Scholar
• VITTE C, FLEISCH H, GUENTHER HL: Biphosphonates in-duce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology (1996) 137:2324–2333.
   PubMed Web of Science ®Google Scholar
• MARTIN TJ, MOSELEY JM, GILLESPIE MT: Parathyroidhormone-related protein: biochemistry and molecu-lar biology. Grit. Rev. Biochem. MoL Biol. (1991) 26:377–395.
   PubMed Web of Science ®Google Scholar
• RIXON RH, WHITFIELD JF, GAGNON L et al.: Parathyroid hormone fragments may stimulate bone growth in ovariectomised rats by activating adenylyl cyclase. J. Bone Miner. Res. (1994) 9:1179–1189.
   PubMed Web of Science ®Google Scholar
• SABATINI M, LESUR C, PACHERIE M et al.: Effects of para-thyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell prolifera-tion. Bone (1996) 18:59–65.
   Google Scholar
• NEUGEBAUER W, BARBIER JR, SUNG WL et al.: solutionstructure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues. Biochemistry (1995) 34:8835–8842.
   Google Scholar
• CAULFIELD MP, MCKEE RL, GOLDMAN ME et al.: The bo-vine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocri-nology (1990) 127:83–87.
   PubMedGoogle Scholar
• KIMMEL DB, BOZZATO RP, KRONIS KA et al.: The effectof recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomised rats. Endocrinology (1993) 132:1577–1584.
   PubMed Web of Science ®Google Scholar
• WHITFIELD JF, MORLEY P, WILLICK GE et al.: Compari-son of the ability of recombinant human parathyroid hormone, RhPTH- (1-84), and HPTH- (1-31)NH2 to stimulate femoral trabecular bone growth in ovariec-tomised rats. Calcif Tissue Intern. (1997) 60:26–29.
   PubMed Web of Science ®Google Scholar
• EJERSTED C, ANDREASSEN TT, HAUGE EM et al.: Parathy-roid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone (1995) 17:507–11.
   PubMed Web of Science ®Google Scholar
• MOSEKILDE L, DANIELSEN CC, SOGAARD CH et al.: The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomised rat model. Bone (1995) 16:223–230.
   PubMed Web of Science ®Google Scholar
• WHITFIELD JF, MORLEY P, ROSS V et al.: Restoration of severely depleted femoral trabecular bone in ovariec-tomised rats by parathyroid hormone-(1-34). Ca/cif Tissue Intern. (1995) 56:227–231.
   Google Scholar
• WHITFIELD JF, MORLEY P, WILLICK GE et al.: Stimulation of the growth of femoral trabecular bone in ovariecto-mised rats by the novel parathyroid hormone frag-ment, HPTH- -30N1-12 (Ostabolin). Calcif. Tissue Intern. (1996) 58:81–87.
   PubMed Web of Science ®Google Scholar
• HODSMAN AB, FRAHER LJ, WATSON PH et al.: A random-ized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J. Clin. Endocrinol. Metab. (1997) 82:620–628.
   PubMed Web of Science ®Google Scholar
• LINDSAY R, NIEVES J, FORMICA C et al.: Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteopo-rosis. Lancet (1997) 350:550–555.
   PubMed Web of Science ®Google Scholar
• NEER M, SLOVIK DM, DALY M et al.: Treatment of post-menopausal osteoporosis with daily parathyroid hor-mone plus calcitriol. Osteoporos. Int. (1993) 3 Suppl 1:204–205.
   Google Scholar
• SLOVIK DM, ROSENTHAL DI, DOPPELT SH et al.: Restora-tion of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J. Bone Miner. Res. (1986) 1:377–381.
   PubMed Web of Science ®Google Scholar
• COHEN FE, STREWLER GJ, BRADLEY MS et al.: Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J. Biol. Chem. (1991) 266:1997–2004.
   Google Scholar
• LANE NE, KIMMEL DB, NILSSON MHL et al.: Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomised rat model. J. Bone Miner. Res. (1996) 11:614–625.
   PubMed Web of Science ®Google Scholar
• JOUISHOMME H, WHITFIELD JF, GAGNON L et al.: Fur-ther definition of the protein kinase c activation do-main of the parathyroid hormone. J. Bone Miner. Res. (1994) 9:943–949.
   PubMed Web of Science ®Google Scholar
• BARBIER JR, NEUGEBAUER W, MORLEY P et al.: Bioactivi-ties and secondary structures of constrained ana-logues of human parathyroid hormone: cyclic lactams of the receptor binding region. J. Med. Chem. (1997) 40:1373–1380.
   PubMed Web of Science ®Google Scholar
• WHITFIELD JF, MORLEY P, WILLICK G et al.: Cyclization by a specific lactam increases the ability of human parathyroid hormone (HPTH) (1 31)14112 to stimulate bone growth in ovariectomized rats. J. Bone Miner. Res. (1997) 12:1246–1252.
   PubMed Web of Science ®Google Scholar
• BISELLO A, NAKAMOTO C, ROSENBLATT M, CHOREV M: Mono- and bicyclic analogs of parathyroid hormone- related protein. 1. Synthesis and biological studies. Biochemistry (1997) 36:3293–3299.
   Google Scholar
• NEUGEBAUER W, SUREWICZ WK, GORDON HL et al.:Structural elements of human parathyroid hormone and their possible relation to biological activities. Bio-chemistry (1992) 31:2056–2063.
   Google Scholar
• VICKERY BH, AVNUR Z, CHENG Y et al. .: RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomised, osteopenic rats. J. Bone Miner. Res. (1996) 11:1943–1951.
   PubMed Web of Science ®Google Scholar
• SOMJEN D, SCHLUTER KD, WINGENDER E et al.: Stimula-tion of cell proliferation in skeletal tissues of the rat by defined parathyroid hormone fragments. Biochem. J. (1991) 277:863–868.
   PubMed Web of Science ®Google Scholar
• SCHLUTER KD, HELLSTERN H, WINGENDER E, MAYER H: The central part of parathyroid hormone stimulates thymidine incorporation of chondrocytes. J. Biol. Chem. (1989) 264:11087–11092.
   PubMed Web of Science ®Google Scholar
• WHITFIELD JF, MORLEY P, ROSS V et al.: The hypotensive actions of osteogenic and nonosteogenic parathyroid hormone fragments. Ca/cif Tissue Intern. (1997) 60:302–308.
   Google Scholar
• FENTON AJ, KEMP BE, HAMMONDS RG JR et al.: A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinol-ogy (1991) 129:3424–3426.
   Google Scholar
• GRAM H, RAMAGE P, MEMMERT K et al.: A novel ap-proach for high level production of a recombinant hu-man parathyroid hormone fragment in Escherichia coll. Biotechnology NY (1994) 12:1017–1023.
   Google Scholar
• HARDER MP, SANDERS EA, WINGENDER E, DECKWER WD: Production of human parathyroid hormone by recombinant Escherichia coil TG1 on synthetic me-dium. J. Biotechnol. (1994) 32:157–164.
   Google Scholar
• HOGSET A, BLINGSMO OR, SAETHER 0 et al.: Expression and characterization of a recombinant human para-thyroid hormone secreted by Escherichia coil em-ploying the staphylococcal protein a promoter and signal sequence. J. Biol. Chem. (1990) 265:7338–7344.
   Google Scholar
• SUNG WL, ZAHAB DM, BARBIER JR et al.: Specific degen-erate codons enhanced selective expression of human parathyroid hormone in Escherichia coll. J. Biol. Chem. (1991) 266:2831–2835.
   Google Scholar
• OSHIKA Y, YAMADA T, NAKAGAWA S et al.: Human para-thyroid hormone: efficient synthesis in Escherichia coil using a synthetic gene, purification and charac-terization. Intern. J. Pept. Protein Res. (1994) 43:441–447.
   Google Scholar
• OLDENBURG KR, D'ORFANI AL, SELICK HE: A method forthe high-level expression of a parathyroid hormone analog in Escherichia coll. Protein Expr. Purif (1994) 5:278–284.
   Google Scholar
• SCHETZ JA, MAYR CA, TAYLOR JE et al Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone- related protein in the rat. J. Pharmacol. Exp. Then (1995) 274:1456–1462.
   PubMed Web of Science ®Google Scholar
• DRESNERPOLLAK R, YANG QM, BEHAR V et al.: Evalua-tion in vivo of a potent parathyroid hormone antago-nist: [N1e8'18,D-Trp12,Tyr34]BPTH(7-34)NH2. I Bone Miner. Res. (1996) 11:1061–1065.
   Google Scholar
• NUSSBAUM SR, ROSENBLATT M, POTTS JT JR: Parathy-roid hormone. Renal receptor interactions, demon-stration of two receptor-binding domains. J. Biol. Chem. (1980) 255:10183–10187.
   Google Scholar
• COLTRERA M, ROSENBLATT M, POTTS JT, Jr.: Analogues of parathyroid hormone containing D-amino acids: evaluation of biological activity and stability. Biochem-istry (1980) 19:4380–4385.
   Google Scholar